KNSA

Kiniksa Pharmaceuticals, Ltd.

21.70 USD
-0.04 (-0.18%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Kiniksa Pharmaceuticals, Ltd. stock is up 18.06% since 30 days ago. The next earnings date is Apr 30, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 March’s closed higher than February. In the last 2 Unusual Options Trades, there were 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
27 Feb 20:12 19 Jul, 2024 17.50 CALL 50 6
28 Feb 16:49 19 Jul, 2024 22.50 CALL 150 15

About Kiniksa Pharmaceuticals, Ltd.

Kiniksa Pharmaceuticals, Ltd. focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease. KPL-404 is a monoclonal antibody inhibitor of the CD40- CD154 interaction, a T-cell co-stimulatory signal critical for B-cell maturation.